Galza-Met Tablets 50mg/850mg

Product Overview

Product Form: Tablet
Pack Size: 30 tablets
Prescription Required: Yes

Galza-Met Tablets 50mg/850mg Details

Galza-Met Tablets 50mg/850mg is a pharmaceutical combination used to manage Type 2 diabetes. Each tablet contains 50mg of Sitagliptin and 850mg of Metformin hydrochloride. This formulation works by regulating blood sugar levels to improve glycemic control in diabetic patients. It is commonly prescribed to individuals who require both Sitagliptin and Metformin for effective diabetes management.

Galza-Met Tablets 50mg/850mg Uses

• Control blood sugar levels in Type 2 diabetes patients
• Improve insulin sensitivity
• Regulate glucose production in the liver
• Lower HbA1c levels
• Manage diabetic complications

How To Use Galza-Met Tablets 50mg/850mg

It is recommended to take Galza-Met Tablets 50mg/850mg as prescribed by your healthcare provider. Typically, the usual dose is one tablet twice daily with meals. Follow the instructions provided by your doctor or pharmacist for the best results. Do not adjust the dosage without consulting a healthcare professional.

Adverse Effects

Some common side effects of Galza-Met Tablets 50mg/850mg may include nausea, diarrhea, abdominal discomfort, headache, and hypoglycemia in some cases. If any of these side effects persist or worsen, notify your doctor promptly. Serious side effects such as lactic acidosis are rare but seek immediate medical attention if you experience symptoms like muscle pain, weakness, or trouble breathing.

Important Warnings & Precautions

It is crucial to inform your healthcare provider about any existing medical conditions, allergies, or medications you are taking before starting Galza-Met Tablets 50mg/850mg. This medication may not be suitable for individuals with kidney or liver issues. Regular monitoring of kidney function is essential during treatment. Avoid excessive alcohol consumption while taking this medication as it may increase the risk of lactic acidosis.

Tags: Type 2 diabetes management, Sitagliptin, Metformin, Blood sugar control, Insulin sensitivity, Glycemic control